Phase III Trial

Here's a look at the top tickers trending on StockTwits.com. Intercept Pharmaceuticals: Phase III trial update Intercept Pharmaceuticals (NASDAQ: ICPT) announced hat its liver disease drug obeticholic acid (OCA) for primary biliary cirrhosis has been successful in its POISE phase III clinical...